OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: University of Alabama at Birmingham

3 Projects | 3 Researchers | $879,810 Invested

2018

University of Alabama at Birmingham

Erik Roberson, MD, PhD

Toward Therapeutic Approaches to TREM2-R47H in Alzheimer’s Disease

  • Funding Amount: $660,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Inflammation
  • Status: Active

2008

University of Alabama at Birmingham

Ray Watts, MD

Oral Amyloid AAV Vaccine for Alzheimer's Disease

  • Funding Amount: $130,794
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2007

University of Alabama at Birmingham

Shaila Handattu, PhD

HDL modulation, Inflammation and Alzheimer’s disease

  • Funding Amount: $89,016
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed